These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3081699)

  • 21. Salicylate therapy in juvenile rheumatoid arthritis. Dose, serum level, and toxicity.
    Doughty RA; Giesecke L; Athreya B
    Am J Dis Child; 1980 May; 134(5):461-3. PubMed ID: 7377152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocytes in rheumatoid arthritis. Regulatory, effector, and phenotypic properties.
    Panush RS
    J Rheumatol; 1985 Dec; 12(6):1053-61. PubMed ID: 4093912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ferritinemia as an indicator of systemic disease activity in children with systemic juvenile rheumatoid arthritis.
    Pelkonen P; Swanljung K; Siimes MA
    Acta Paediatr Scand; 1986 Jan; 75(1):64-8. PubMed ID: 3953279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA studies in IgM rheumatoid-factor-positive arthritis of childhood.
    Clemens LE; Albert E; Ansell BM
    Ann Rheum Dis; 1983 Aug; 42(4):431-4. PubMed ID: 6603824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case report: immunoglobulin A deficiency in patients with juvenile rheumatoid arthritis treated with aspirin.
    Kondo N; Takao A; Orii T
    Biotherapy; 1993; 7(1):59-62. PubMed ID: 8068484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunosuppressive therapy of rheumatoid arthritis in children].
    Shakhbazian IE; Ulybina OV
    Vopr Revm; 1978; (1):21-3. PubMed ID: 654192
    [No Abstract]   [Full Text] [Related]  

  • 27. Intermediate monocytes are increased in enthesitis-related arthritis, a category of juvenile idiopathic arthritis.
    Gaur P; Myles A; Misra R; Aggarwal A
    Clin Exp Immunol; 2017 Feb; 187(2):234-241. PubMed ID: 27706807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced bone mineral content and normal serum osteocalcin in non-steroid-treated patients with juvenile rheumatoid arthritis.
    Polito C; Strano CG; Rea L; Alessio M; Iammarrone CS; Todisco N; Marotta A; Iaccarino E; Pirozzi M
    Ann Rheum Dis; 1995 Mar; 54(3):193-6. PubMed ID: 7748017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR; Keating GM
    Drugs; 2002; 62(17):2493-537. PubMed ID: 12421111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis.
    Funk RS; Chan MA; Becker ML
    Pharmacotherapy; 2017 Jun; 37(6):700-711. PubMed ID: 28475276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anemia in patients with juvenile rheumatoid arthritis.
    Koerper MA; Stempel DA; Dallman PR
    J Pediatr; 1978 Jun; 92(6):930-3. PubMed ID: 660358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Juvenile rheumatoid arthritis. Monocyte dysfunction in selected patients.
    Marek-Szydlowska T; Uracz W; Ruggiero I; Pietrzyk JJ; Zembala M
    Clin Pediatr (Phila); 1988 Nov; 27(11):551-6. PubMed ID: 3180629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic onset juvenile rheumatoid arthritis presenting with absence of B lymphocytes.
    Artac H; Alp H; Keles S; Reisli I; Tunc R
    Rheumatol Int; 2007 Aug; 27(10):981-3. PubMed ID: 17252261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum soluble CD23 levels and CD23 expression on peripheral blood mononuclear cells in juvenile chronic arthritis.
    Massa M; Pignatti P; Oliveri M; De Amici M; De Benedetti F; Martini A
    Clin Exp Rheumatol; 1998; 16(5):611-6. PubMed ID: 9779313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Juvenile Idiopathic Arthritis.
    Barut K; Adrovic A; Şahin S; Kasapçopur Ö
    Balkan Med J; 2017 Apr; 34(2):90-101. PubMed ID: 28418334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the effect of D-penicillamine, gold thioglucose and methotrexate on streptococcal cell wall arthritis.
    Ridge SC; Rath N; Galivan J; Zabriske J; Oronsky AL; Kerwar SS
    J Rheumatol; 1986 Oct; 13(5):895-8. PubMed ID: 3102727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Double-blind evaluation of the therapeutic efficacy of D-penicillamine and hydroxychloroquine in juvenile rheumatoid arthritis].
    Kuz'mina NN; Briuér EI; Isaeva LA; Alekseev LS; Shokh BP
    Revmatologiia (Mosk); 1987; (1):7-12. PubMed ID: 3299632
    [No Abstract]   [Full Text] [Related]  

  • 38. Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis.
    Graham LD; Myones BL; Rivas-Chacon RF; Pachman LM
    J Pediatr; 1992 Mar; 120(3):468-73. PubMed ID: 1538301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathogenesis and therapy of rheumatoid inflammation].
    Dreher R; Röbe-Oltmanns B; Fink K; Seidel H
    Immun Infekt; 1986 May; 14(3):100-8. PubMed ID: 3486811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic use of etanercept in polyarticular course juvenile idiopathic arthritis over a two year period.
    Kietz DA; Pepmueller PH; Moore TL
    Ann Rheum Dis; 2002 Feb; 61(2):171-3. PubMed ID: 11796406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.